Skip to main content

Allogene Therapeutics: Q4 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Thursday reported a loss of $38.8 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 17 cents.

The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

For the year, the company reported that its loss narrowed to $190.9 million, or 87 cents per share.

In the final minutes of trading on Thursday, the company’s shares hit $2.47. A year ago, they were trading at $2.06.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story

Related Stories

Knicks take 1-0 lead into game 2 against the Spurs

Beijing bans 4 New Zealand lawmakers from entering China because they visited Taiwan

Police warn families of Tiananmen crackdown dead not to visit graves on 37th anniversary